17/12/2009 - Australian Drug Hope: Biotron Progresses Breakthrough HIV Treatment
14/12/2009 - Biotron Hepatitis C Success: International Conference told of New Drug Hope
10/12/2009 - Option Entitlement Issue
10/11/2009 - Biotron's Anti-HCV Drug Recognised Internationally
16/10/2009 - Results of Annual General Meeting
16/10/2009 - Presentation to Annual General Meeting
14/10/2009 - Shareholder Update - October edition of
BITNews
6/10/2009 - Successful HCV Trial Results
29/09/2009 - Annual Report for year ended 30 June 2009 and Notice of Annual General Meeting
28/08/2009 - Year End Accounts and Preliminary Final Report for year ended 30 June 2009
4/08/2009 - Completion of Clinical Stage of HCV Trial
24/07/2009 - Appendix 4C - Quarterly Report 30 June 2009
29/04/2009 - Appendix 4C - Quarterly Report 31 March 2009
14/04/2009 - New Issue Announcement - HCV Trial Update
6/04/2009 - Change of Director's Interest Notice
5/03/2009 - Details of Biotron Share Purchase Plan
24/02/2009 - Biotron Share Purchase Plan
12/02/2009 - Appendix 4D - Half Year Report 31 December 2008
12/02/2009 - BIT225 HIV Data Presented at International Meeting
30/01/2009 - Appendix 4C - Quarterly Report 31 December 2008
Home
> News & Research > ASX Announcements > 2009
Latest share price
ASX:BIT
Home
About
Company overview
People
Technology
Programs
Pipeline
Hepatitis C virus
HIV
Discovery antiviral programs
Intellectual property
Key publications
Reports
Annual
Half-yearly
Quarterly
News & Research
ASX announcements
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Newsletters
Biotron in the media
Research
Presentations
Corporate Directory
Corporate Directory
Shareholder services
FAQ
Contacts